Oramed Pharmaceuticals Inc. (ORMP)

Oramed Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Aug 31, 2021
Cash & Equivalents	74.52	54.42	9.06	40.46	27.46	77.25
Short-Term Investments	56.13	87.51	152.99	115.26	118.82	16.9
Cash & Short-Term Investments	130.64	141.93	162.05	155.72	146.28	94.14
Cash Growth	-26.02%	-12.41%	4.06%	6.45%	55.39%	-
Prepaid Expenses	0.62	1.29	0.54	1.39	1.66	1.2
Total Current Assets	131.48	143.22	162.58	157.11	147.94	95.34
Property, Plant & Equipment	1.01	1.11	1.57	1.8	0.89	0.93
Long-Term Investments	9.53	10.91	56.37	2.7	3.88	6.69
Other Long-Term Assets	1.26	0.03	0.03	0.03	25.12	25.04
Total Assets	147.54	155.28	220.55	161.64	177.82	128
Accounts Payable	0.51	0.79	0.55	2.18	1.69	2.61
Accrued Expenses	1.01	1.48	1.38	1.97	2.31	1.2
Short-Term Debt	-	-	51.01	-	-	-
Current Portion of Leases	0.18	0.22	0.27	0.25	0.13	0.13
Current Income Taxes Payable	3.79	3.2	-	-	-	-
Current Unearned Revenue	-	-	-	1.34	2.7	2.7
Other Current Liabilities	-	-	-	0.01	0.53	0.04
Total Current Liabilities	5.49	5.69	53.21	5.75	7.37	6.68
Long-Term Leases	0.12	0.16	0.34	0.65	0.37	0.4
Long-Term Unearned Revenue	2	4	4	4	3.34	4.24
Other Long-Term Liabilities	-	0.06	0.07	0.07	0.11	0.14
Total Liabilities	7.65	9.93	57.66	10.49	11.21	11.48
Common Stock	0.49	0.48	0.49	0.48	0.46	0.42
Additional Paid-In Capital	324.58	322.4	320.89	314.42	292.51	230.2
Retained Earnings	-184.26	-176.62	-157.56	-163.08	-126.52	-114.85
Total Common Equity	140.81	146.27	163.82	151.81	166.45	115.77
Minority Interest	-0.92	-0.92	-0.93	-0.66	0.16	0.74
Shareholders' Equity	139.89	145.35	162.89	151.16	166.61	116.52
Total Liabilities & Equity	147.54	155.28	220.55	161.64	177.82	128
Total Debt	0.3	0.37	51.62	0.89	0.5	0.53
Net Cash (Debt)	130.34	141.56	112.23	154.83	149.66	100.3
Net Cash Growth	-10.76%	26.13%	-27.51%	3.45%	49.21%	-
Net Cash Per Share	3.18	3.47	2.77	3.97	4.03	3.52
Filing Date Shares Outstanding	40.85	40.85	40.52	39.78	38.56	38.09
Total Common Shares Outstanding	40.85	39.92	40.34	39.56	38.16	35.29
Working Capital	125.98	137.54	109.37	151.36	140.57	88.66
Book Value Per Share	3.45	3.66	4.06	3.84	4.36	3.28
Tangible Book Value	140.81	146.27	163.82	151.81	166.45	115.77
Tangible Book Value Per Share	3.45	3.66	4.06	3.84	4.36	3.28

Updated Nov 7, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q